Our Team

Chief Clinical Trials Officer: Gerson Hernandez, M.D.

Dr. Hernandez research focuses on the development of therapeutics to prevent and treat age-associated neurodegenerative diseases. He has over 10 years of experience with clinical trials in Alzheimer’s disease and women’s health.

Dr. Hernandez earned a medical degree from the Francisco Marroquin School of Medicine. He also completed post-doctoral training in clinical research and acquired a Master of Public Health degree at the Keck School of Medicine of the University of Southern California.

His ultimate goal is to deliver precision therapeutics, discovered in bench research and tested in innovative clinical trials, to medical practice that will yield meaningful health outcomes in patients with neurodegenerative diseases.

<Back

Previous
Previous

John Rinehart, MBA, MA, Chief Executive Officer

Next
Next

Dr. Kathy Rodgers, Ph.D., Chief Science Officer